Gonzalez-Rivas PA, Chambers M, Liu J Journal of veterinary pharmacology and therapeutics 2021
Guest Episode Womens health and performance: how training, nutrition, and hormones interact across life stages Guest Episode Rethinking nutrition science: the evolving landscape of obesity treatment, GLP-1 agonists, protein, and the need for higher research standards Podcast Episode Insulin resistance masterclass: The full body impact of metabolic dysfunction and prevention, diagnosis, and treatment Guest Episode The science of resistance training, building muscle, and anabolic steroid use in bodybuilding Guest Episode A new era of longevity science: models of aging, human trials of rapamycin, biological clocks, promising compounds, and lifestyle interventions Guest Episode Rethinking protein needs for performance, muscle preservation, and longevity, and the mental and physical benefits of creatine supplementation and sauna use AMA Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent Guest Episode The protein debate: optimal intake, limitations of the RDA, whether high-protein intake is harmful, and how to think about processed foods AMA Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins AMA GLP-1 Agonists The Future of Treating Obesity
Many of the stakeholder implications that accompany the FDAs announcement of the resolution affect the community pharmacies, telehealth companies, and other providers managing patient care on the front lines
Thus, with a common pathophysiology, it could be considered a single condition, although individual patients have different genetic predispositions that feed into this vicious cycle (Figure 1)
Details on how Ivm Health intends to incorporate oral options appear on our oral GLP-1 medication page
